|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improvepatient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR). |
| 公司地址
| Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327 |
| 電話號碼
| +49 69870039170 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.anbio.com |
| 員工數量
| 27 |
| Mr. Michael Lau |
Chief Executive Officer |
-- |
07/04/2026 |
| Ms. Suki Song |
Chief Financial Officer |
-- |
07/04/2026 |
| Mr. Chris Tian |
Chief Business Officer |
-- |
07/04/2026 |
|
|
| Mr. Michael W. Zhang |
Independent Director |
07/04/2026 |
| Mr. Cany Xu |
Director |
07/04/2026 |
| Ms. Nancy Hartzler |
Independent Director |
07/04/2026 |
| Mr. David Hsu |
Independent Director |
07/04/2026 |
|
|
|
|